论文部分内容阅读
目的观察肾康注射液降低腹膜透析患者微炎症反应状态,改善患者营养状况,探讨其治理机制。方法将10例持续CRP增高半年以上及白蛋白持续低于正常值的腹膜透析患者给予肾康注射液治疗4周,复查CRP值、白蛋白值,观察临床疗效。结果肾康注射液在一定程度上能降低CRP值,减轻腹膜透析患者微炎症反应状态,并提高白蛋白值,改善营养状况,有统计学意义。结论肾康注射液利于改善腹膜透析患者微炎症反应状态,提高白蛋白值,改善患者营养状况。
Objective To observe the effect of Shenkang injection on reducing microinflammatory reaction in patients undergoing peritoneal dialysis, improve the nutritional status of patients and explore its mechanism. Methods Ten patients with persistent peritoneal dialysis whose serum CRP level increased more than six months and albumin level continued to be lower than the normal value were given Shenkang injection for 4 weeks. The CRP and albumin values were examined and the clinical efficacy was observed. Results Shenkang injection can reduce the CRP to a certain extent, reduce the micro-inflammatory response in patients with peritoneal dialysis and improve albumin values, improve the nutritional status, with statistical significance. Conclusion Shenkang injection can improve the microinflammatory response of peritoneal dialysis patients, raise the albumin value and improve the nutritional status of patients.